A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
about
EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancerClinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation.Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
P2860
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@en
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@nl
type
label
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@en
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@nl
prefLabel
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@en
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@nl
P2093
P2860
P1433
P1476
A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
@en
P2093
Huijie Wang
Jialei Wang
Jianhua Chang
Kailin Xing
Xianghua Wu
Xiaoyan Zhou
Xinmin Zhao
P2860
P2888
P356
10.1007/S12032-014-0036-2
P577
2014-06-08T00:00:00Z